Cognitive-Motor Training for AD/ADRD Prevention
Innovative Cognitive-Motor Training for Prevention of AD/ADRD
1 other identifier
interventional
46
1 country
1
Brief Summary
Alzheimer's disease and related dementias (AD/ADRD) greatly affect memory and daily activities in older adults. Mild Cognitive Impairment (MCI) is an early stage of dementia, affecting about 17% of older adults. People with MCI often show problems with gait and balance, which doubles their risk of falling compared to cognitively healthy peers. Falls can cause injuries, increase sedentary behavior, and reduce physical activity. This decline in activity can also speed up the progression from MCI to dementia. Exercise can help older adults make healthy lifestyle changes; however, most of the existing exercise programs focus mainly on physical movement rather than cognitive function. Therefore, the investigators developed a new program that uses computer vision and a cloud-based system to provide more scalable, engaging, and personalized cognitive-motor training for OAwMCI. The purpose of this study is to investigate the short- and long-term effects of a novel CogXergaming training (CXT) paradigm for improving the cognitive-motor function, physical activity, falls efficacy, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
March 24, 2026
March 1, 2026
1 year
August 29, 2025
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Dual-task Limits of Stability Test (LOS)
Measures changes in max excursion under dual-task conditions during the LOS test compared to the single-task.
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
Mini-BESTest
Assesses 4 domains: anticipatory and reactive balance control (therapist-induced), sensory orientation, and gait. The value ranges from 0 to 28, and higher scores indicate better balance control.
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
Physical Activity Scale of Elderly (PASE)
Self-reported measure of physical activity levels in older adults. The score ranges from 0 to 799, higher scores indicate greater physical activity level.
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
Activities Specific Balance Confidence (ABC)
Assesses an individual's confidence in maintaining balance during various daily activities. The score ranges from 0 to 100, and higher scores indicate greater confidence in maintaining balance during activities
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
Secondary Outcomes (7)
Dual-task Stance Perturbation Test (SPT)
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
Timed up and go (TUG)
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
6 Minute Walk Test (6MWT)
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
NIH motor toolbox- standing balance test
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
NIH motor toolbox- 4-meter walking test.
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
- +2 more secondary outcomes
Other Outcomes (1)
The NIH Toolbox Fluid Cognition Composite Score
Baseline (session 1) and immediate post-training (session 20), and 2-month post-training (session 21)
Study Arms (2)
Novel CogXergaming Training
EXPERIMENTALCustomized Novel CogXergaming Training based on cognitive-motor balance training will be delivered to Participants in group A. Participants will undergo 18 sessions of training for eight weeks, with around 60 minutes of training per session, i.e., 3 sessions per week in the first 2 weeks, and 2 sessions per week in the remaining 6 weeks. All the CXT training will be performed using a desktop with a webcam.
Exercise and Education Training Program
EXPERIMENTALParticipants in Group B will complete 8 weeks of a conventional exercise program and fall-prevention education (3x/week in the first 2 weeks and 2x/week in the remaining 6 weeks, 18 sessions total) in the lab.
Interventions
In each session, participants will play 6 games in the same order (Fruit catch, Math, Tracking, Candy match, Letter Number Sequencing - LNS, Stroop), each of which contains 10-20 trials and will last for around 10 minutes (total = 60 minutes. The CXT program employs a progressive method to ensure the intensity of CXT remains challenging without overload. If a participant demonstrates ≥80% accuracy in 3 continuous trials for one game, then the exercises for this game will be progressed to the next level (levels: 1-9 in Table 3). Each session of CXT will last approximately 1 hour. At least one day of rest will be required between weekly training sessions.
EEP consists of a conventional exercise program and fall-prevention education. The conventional exercise program comprises 50 minutes of supervised exercises for stretching and strengthening. A fall-prevention education program will also be provided to Group B, for about 10 minutes after each session of the exercise program. Each session of EEP will last approximately 1 hour. At least one day of rest will be required between weekly training sessions.
Eligibility Criteria
You may qualify if:
- Age: 55-90 years.
- No recent major surgery, bone fracture, or hospitalization (\< 3 months).
- Not on any sedative drugs.
- Can understand and communicate in English.
- Can walk without an assistive device for at least 1 block to ensure independent functioning.
- Identification of Mild Cognitive Impairment (MCI) based on Jak/Bondi criteria
- Visual acuity greater than or equal to 20/40 with or without corrective lenses to ensure intact vision.
You may not qualify if:
- Participants will not proceed with the study if any of the following occurs at baseline measurement: 1) Heart Rate \>85% of age-predicted maximal heart rate (HRmax) (HRmax = 220 - age), 2) systolic blood pressure (SBP) \> 160 mmHg and/or diastolic blood pressure (DBP) \> 110 mmHg during resting.
- Unable to stand for 5 minutes without an assistive device and walk for 10 m without an assistive device
- Complaints of shortness of breath, or uncontrolled pain (more than 3 out of 10 on Visual Analogue Scale), or if pulse oxygen drops less than 92% on the six-minute walk test (for endurance) to ensure that the participant can effectively participate without discomfort or injury during testing and training.
- Exhibits difficulty understanding the study information.
- Self-reported history or presence of any neurological, musculoskeletal, cardiorespiratory, or systemic disorders that significantly impact mobility or the ability to walk independently (without an assistive device).
- Self-reported disability (with or without an assistive device) to ensure independent functioning.
- Uncontrolled (not under any medications) hypertension to avoid cardiovascular complications during testing/training.
- Weight \>220 lbs (harness weight threshold).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shuaijie Wang, PhD
University of Illinois at Chicago
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
August 29, 2025
First Posted
September 8, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
March 24, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share